3 October 2024 - Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.

NHS England proposes that patients likely to achieve the greatest clinical benefit from weight loss are prioritised to receive the medication in a variety of new services that will be tested before an expansion of the drug’s availability.

Read NICE press release